Home › Multiple Sclerosis › Texas › Plano
Multiple Sclerosis clinical trials in Plano, TX
3 studies for Multiple Sclerosis are looking for participants at sites in and around Plano (within about 30 miles). Open a study to see who can join and how to contact the study team.
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
RecruitingPhase 3
- North Texas Institute of Neurology & Headache - Plano- Site Number : 8400082, Plano
- North Texas Institute of Neurology & Headache - Plano- Site Number : 8400083, Plano
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
RecruitingPhase 3
- Saturn Research Solution, Plano
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
RecruitingPhase 2
- Saturn Research Solutions, Plano
About Multiple Sclerosis
Multiple sclerosis (MS) slows down or blocks messages between the brain and body. MS can be mild or severe. Learn about MS symptoms and treatment.
More about Multiple Sclerosis on MedlinePlus
Multiple Sclerosis trials in other cities
- New York City, NY17 studies
- Chicago, IL15 studies
- Boston, MA14 studies
- Washington, DC13 studies
- Cleveland, OH9 studies
- St. Louis, MO8 studies
- Kansas City, KS8 studies
- Birmingham, AL8 studies
- San Francisco, CA8 studies
- Seattle, WA7 studies
- Columbus, OH7 studies
- Baltimore, MD7 studies
Other studies in Plano
- Heart Failure11 studies
- Cardiovascular Disease9 studies
- Coronary Artery Disease8 studies
- Depression6 studies
- Aortic Valve Stenosis6 studies
- Non-Small Cell Lung Cancer5 studies
- Major Depressive Disorder5 studies
- Aortic Dissection4 studies
- Peripheral Arterial Disease4 studies
- Obesity4 studies
- Aortic Valve Insufficiency3 studies
- Abdominal Aortic Aneurysm3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.